Hypoxia signaling: Challenges and opportunities for cancer therapy

被引：31

作者：

Ivan, Mircea ^{[1
,2
]}

Fishel, Melissa L. ^{[3
,4
]}

Tudoran, Oana M. ^{[5
]}

Pollok, Karen E. ^{[3
]}

Wu, Xue ^{[6
]}

Smith, Paul J. ^{[7
]}

机构：

[1] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA

[2] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN USA

[3] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN USA

[4] IU Simon Comprehens Canc Ctr, Dept Pharmacol & Toxicol, Indianapolis, IN USA

[5] Oncol Inst Prof Dr Ion Chiricuta, Cluj Napoca, Cluj, Romania

[6] Ohio State Univ, Columbus, OH USA

[7] Cardiff Univ, Sch Med, Cardiff, Wales

来源：

SEMINARS IN CANCER BIOLOGY | 2022年 / 85卷

关键词：

Hypoxia; HIF1; HIF2; HIF inhibitors; Hypoxia-activated prodrug; SMALL-MOLECULE INHIBITOR; ANTI-ANGIOGENIC THERAPY; DNA TOPOISOMERASE-II; CYTOCHROMES P450 CYP; RENAL-CELL CARCINOMA; INDUCIBLE FACTOR; ACTIVATED PRODRUG; N-OXIDE; HEPATOCELLULAR-CARCINOMA; PROLYL HYDROXYLASE;

D O I：

10.1016/j.semcancer.2021.10.002

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Hypoxia is arguably the first recognized cancer microenvironment hallmark and affects virtually all cellular populations present in tumors. During the past decades the complex adaptive cellular responses to oxygen deprivation have been largely elucidated, raising hope for new anti cancer agents. Despite undeniable preclinical progress, therapeutic targeting of tumor hypoxia is yet to transition from bench to bedside. This review focuses on new pharmacological agents that exploit tumor hypoxia or interfere with hypoxia signaling and discusses strategies to maximize their therapeutic impact.

引用

页码：185 / 195

页数：11

共 50 条

[21] Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment
Benjamin J. Moeller
Rachel A. Richardson
Mark W. Dewhirst
Cancer and Metastasis Reviews, 2007, 26 : 241 - 248
[22] Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment
Moeller, Benjamin J.
Richardson, Rachel A.
Dewhirst, Mark W.
CANCER AND METASTASIS REVIEWS, 2007, 26 (02) : 241 - 248
[23] Hypoxia and Oxygen-Sensing Signaling in Gene Regulation and Cancer Progression
Yang, Guang
Shi, Rachel
Zhang, Qing
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 24
[24] Angiogenesis and immune checkpoint dual blockade: Opportunities and challenges for hepatocellular carcinoma therapy
Li, Si-Qi
Yang, Yang
Ye, Lin-Sen
WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (42) : 6034 - 6044
[25] Tumour hypoxia, hypoxia signaling pathways and hypoxia inducible factor expression in human cancer
Giatromanolaki, A
Harris, AL
ANTICANCER RESEARCH, 2001, 21 (6B) : 4317 - 4324
[26] Challenges Coexist with Opportunities: Spatial Heterogeneity Expression of PD-L1 in Cancer Therapy
Wang, Yazhen
Zhou, Yang
Yang, Lianyi
Lei, Lei
He, Bin
Cao, Jun
Gao, Huile
ADVANCED SCIENCE, 2024, 11 (01)
[27] Cervical cancer stem cells: opportunities and challenges
Chhabra, Ravindresh
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (11) : 1889 - 1897
[28] Hypoxia signaling in cancer: Implications for therapeutic interventions
Zhuang, Yan
Liu, Kua
He, Qinyu
Gu, Xiaosong
Jiang, Chunping
Wu, Junhua
MEDCOMM, 2023, 4 (01):
[29] MicroRNAs as Potential Biomarkers in Cancer: Opportunities and Challenges
Lan, Huiyin
Lu, Haiqi
Wang, Xian
Jin, Hongchuan
BIOMED RESEARCH INTERNATIONAL, 2015, 2015
[30] The role of YWHAZ in cancer: A maze of opportunities and challenges
Gan, Yun
Yee, Feng
He, Xing-Xing
JOURNAL OF CANCER, 2020, 11 (08): : 2252 - 2264

← 1 2 3 4 5 →